Clinical trial Recruiting at 1 site Interventional Ages 15 to 25

Lifestyle intervention for adolescents and young adults with congenital heart disease

Official title: Establishing Efficacy for the Congenital Heart Disease Physical Activity Lifestyle Intervention

Run by Nationwide Children's Hospital · NCT06003023 · Data updated 2026-11-12

This study is testing a personalized program to help teenagers and young adults with congenital heart disease get active and improve their heart health.

More Cardiovascular Disease trials

Quick facts

Study typeInterventional
Ages15 Years to 25 Years
SexAll
Enrollment144 (estimated)
SponsorNationwide Children's Hospital
Academic / other
Locations1 site (Columbus, Ohio)
StatusRecruiting
StartedJuly 18, 2023
Main results expectedJuly 30, 2027
Study endsJuly 30, 2027
Registry record updatedJune 1, 2026
Trial IDNCT06003023 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are adolescents and young adults aged 15-25 years with moderate or complex congenital heart disease who are receiving care from a cardiologist.

Probably not a fit

Patients who are already engaging in high levels of physical activity or have contraindications to exercise may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

The Congenital Heart Disease Physical Activity Lifestyle Intervention Study (CHD-PALS) V.2 aims to evaluate the effectiveness of a tailored lifestyle intervention program for adolescents and young adults (AYAs) diagnosed with congenital heart disease (CHD). This program focuses on promoting safe physical activity through individualized guidance provided by trained health professionals. The intervention is based on the Theory of Planned Behavior and includes goal-setting and self-monitoring components to encourage participants to engage in regular physical activity. The study will randomize 144 participants to assess the impact of this intervention on cardiovascular health outcomes.

Why it matters

Potential benefit: If successful, this intervention could significantly improve cardiovascular health and quality of life for adolescents and young adults with congenital heart disease.

How similar studies have gone: Previous studies have shown positive outcomes with lifestyle interventions for improving physical activity and cardiovascular health in similar populations, indicating a promising approach.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Between the ages of 15-25 years
* Diagnosed with moderate or complex structural CHD
* Actively receiving care from a cardiologist at Nationwide Children's Hospital (NCH) or Ohio State University (OSU)

Exclusion Criteria:

* Unable to speak and read proficiently in English
* Have a diagnosis of a genetic syndrome that impacts multiple organ systems
* Have cognitive impairments that would interfere with completing study measures
* Have been engaged in a formal exercise program within the past 6 months,
* Have participated in the intervention arm of the previous CHD-PAL Study
* Have undergone open-heart surgery or had a valve replacement in the last 3 months
* Are unable to complete an exercise stress test using a treadmill
* Are pregnant
* Are prohibited to engage in at least moderate levels of physical activity by their cardiologist
* Engage in \>30 minutes of moderate-to-vigorous physical activity per day, on average per accelerometer
* Have contraindications for exercise based on an exercise stress test (e.g., exercise-induced arrhythmias or evidence of cardiac ischemia)

Where it's running

  • Nationwide Children's Hospital
    Columbus, Ohio, United States
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.